
Keywords: پروپتانلین; ANOVA; analysis of variance; AUC0-4; area under the curve of plasma concentration versus time from 0 to 4â¯h; BA0-4; bioavailability from 0 to 4â¯h; BCS; biopharmaceutics classification system; CEL; celecoxib; Cmax; maximum plasma concentration; COX